Medifast (MED)
NYSE:MED
Want to see MED full AI Analyst Report?
Total Valuation
Medifast has a market cap or net worth of $140.43M. The enterprise value is $84.56M.
Market Cap$140.43M
Enterprise Value$84.56M
Share Statistics
Medifast has 11,119,115 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,119,115
Owned by Insiders5.33%
Owned by Institutions14.40%
Financial Efficiency
Medifast’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -6.50%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-6.50%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee765.45K
Profits Per Employee-37.05K
Employee Count504
Asset Turnover1.50
Inventory Turnover5.47
Valuation Ratios
The current PE Ratio of Medifast is ―. Medifast’s PEG ratio is 0.00631.
PE Ratio―
PS Ratio0.30
PB Ratio0.59
Price to Fair Value0.59
Price to FCF93.90
Price to Operating Cash Flow37.28
PEG Ratio0.00631
Income Statement
In the last 12 months, Medifast had revenue of 385.79M and earned -18.67M in profits. Earnings per share was -1.70.
Revenue385.79M
Gross Profit275.19M
Operating Income-14.21M
Pretax Income-5.64M
Net Income-18.67M
EBITDA-3.71M
Earnings Per Share (EPS)-1.70
Cash Flow
In the last 12 months, operating cash flow was 3.72M and capital expenditures -5.19M, giving a free cash flow of -1.47M billion.
Operating Cash Flow3.72M
Free Cash Flow-1.47M
Free Cash Flow per Share-0.13
Dividends & Yields
Medifast pays an annual dividend of $1.65, resulting in a dividend yield of ―
Dividend Per Share$1.65
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.68
52-Week Price Change-6.11%
50-Day Moving Average11.02
200-Day Moving Average11.85
Relative Strength Index (RSI)65.24
Average Volume (3m)206.56K
Important Dates
Medifast upcoming earnings date is Aug 10, 2026, After Close (Confirmed).
Last Earnings DateMay 4, 2026
Next Earnings DateAug 10, 2026
Ex-Dividend Date―
Financial Position
Medifast as a current ratio of 4.69, with Debt / Equity ratio of 8.14%
Current Ratio4.69
Quick Ratio4.22
Debt to Market Cap0.09
Net Debt to EBITDA19.53
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medifast has paid 13.03M in taxes.
Income Tax13.03M
Effective Tax Rate-2.31
Enterprise Valuation
Medifast EV to EBITDA ratio is -12.05, with an EV/FCF ratio of 35.84.
EV to Sales0.12
EV to EBITDA-12.05
EV to Free Cash Flow35.84
EV to Operating Cash Flow6.52
Balance Sheet
Medifast has $168.95M in cash and marketable securities with $16.10M in debt, giving a net cash position of $152.84M billion.
Cash & Marketable Securities$168.95M
Total Debt$16.10M
Net Cash$152.84M
Net Cash Per Share$13.75
Tangible Book Value Per Share$18.11
Margins
Gross margin is 70.12%, with operating margin of -3.68%, and net profit margin of -4.84%.
Gross Margin70.12%
Operating Margin-3.68%
Pretax Margin-1.46%
Net Profit Margin-4.84%
EBITDA Margin-0.96%
EBIT Margin-3.68%
Analyst Forecast
The average price target for Medifast is $12.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$12.00
Price Target Upside9.39% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-36.31%
EPS Growth Forecast-184.77%